|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print June 1, 2005 J. Lipid Res., doi:10.1194/jlr.M500034-JLR200
Chemistry Dept., Chemistry Research Laboratory, University of Oxford, Oxford OX1 3TA
Corresponding Author: tim.searls{at}chem.ox.ac.uk
Phytanoyl-CoA 2-hydroxylase (PAHX), a non-haem iron(II) and 2-oxoglutarate (2OG)-dependent oxygenase, catalyzes the a-hydroxylation of phytanoyl-CoA within peroxisomes. Mutations in PAHX result in some forms of Adult Refsums Disease. The unprocessed protein (pro-PAHX) contains an N-terminal peroxisomal targeting sequence, which is cleaved to give the mature form of PAHX (mature-PAHX). Previous studies have implied a difference in the substrate selectivity of the pro- and mature- forms of PAHX. We demonstrate that both forms accept a range of coenzyme A (CoA) derivatives, but that the pro-form was consistently less active than the mature form. The lack of activity previously reported for some of these (e.g. isovaleryl-CoA) for the pro-form of PAHX probably arises from differences in the assay conditions in some previous studies, including the presence of ATP. Site-directed mutagenesis was used to test proposals for the identity of the iron-binding ligands (His-175, Asp-177 and His-264) of PAHX. Mutation of other histidine residues (His-213, His-220, His-259) to alanine suggested that these residues were not involved in iron(II) binding, but that His-213 and His-259 may play a structural role. With the Q176A and Q176K mutants, the latter of which is observed in Refsums patients, uncoupling of 2OG oxidation from phytanoyl-CoA hydroxylation was observed.
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||